Projects per year
Abstract
Blue supergiants are the brightest stars in their host galaxies, and yet their evolutionary status has been a long-standing problem in stellar astrophysics. In this pioneering work, we present a large sample of 59 early B-type supergiants in the Large Magellanic Cloud with newly derived stellar parameters and identify the signatures of stars born from binary mergers among them. We simulate novel 1D merger models of binaries consisting of post main-sequence giants with helium-rich cores (primaries) and main-sequence companions (secondaries), and consider the effects of interaction of the secondary with the core of the primary along with the mixing induced by the merger in the envelope. Thereafter, the evolution of the newborn 17-43 M ⊙ stars is followed until core-carbon depletion, close to their final pre-explosion stage. Unlike stars born alone with comparable masses, stars born from mergers of evolved binaries are blue throughout their core helium-burning phase and replicate the surface gravities and Hertzsprung-Russell diagram positions of most of our sample, thus indicating that B-type supergiants structurally resemble stars born from such mergers. Moreover, the large nitrogen-to-carbon and nitrogen-to-oxygen number ratios, coupled with helium enhancements exhibited by at least half our data sample, is uniquely reproduced by our merger models. Collectively, these findings provide compelling evidence toward the important role of binary mergers in producing the currently observed population of blue supergiants in our Universe.
Original language | English |
---|---|
Article number | L42 |
Number of pages | 12 |
Journal | The Astrophysical Journal Letters |
Volume | 963 |
Issue number | 2 |
DOIs | |
Publication status | Published - 10 Mar 2024 |
Projects
- 1 Finished
-
ARC Centre of Excellence for Integrative Brain Function
Egan, G. (Primary Chief Investigator (PCI)), Rosa, M. (Chief Investigator (CI)), Lowery, A. (Chief Investigator (CI)), Stuart, G. (Chief Investigator (CI)), Arabzadeh, E. (Chief Investigator (CI)), Skafidas, E. S. (Chief Investigator (CI)), Ibbotson, M. (Chief Investigator (CI)), Petrou, S. (Chief Investigator (CI)), Paxinos, G. (Chief Investigator (CI)), Mattingley, J. (Chief Investigator (CI)), Garrido, M. (Chief Investigator (CI)), Sah, P. K. (Chief Investigator (CI)), Robinson, P. A. (Chief Investigator (CI)), Martin, P. (Chief Investigator (CI)), Grunert, U. (Chief Investigator (CI)), Tanaka, K. (Partner Investigator (PI)), Mitra, P. (Partner Investigator (PI)), Johnson, G. (Partner Investigator (PI)), Diamond, M. (Partner Investigator (PI)), Margrie, T. (Partner Investigator (PI)), Leopold, D. (Partner Investigator (PI)), Movshon, J. (Partner Investigator (PI)), Markram, H. (Partner Investigator (PI)), Victor, J. (Partner Investigator (PI)), Hill, S. (Partner Investigator (PI)) & Jirsa, V. K. (Partner Investigator (PI))
Australian National University (ANU), Eidgenössische Technische Hochschule Zürich (ETH Zürich) (Federal Institute of Technology Zurich), Australian Research Council (ARC), Karolinska Institutet (Karolinska Institute), Council of the Queensland Institute of Medical Research (trading as QIMR Berghofer Medical Research Institute), Ecole Polytechnique Federale de Lausanne (EPFL) (Swiss Federal Institute of Technology in Lausanne) , Monash University, University of Melbourne, University of New South Wales (UNSW), University of Queensland , University of Sydney, Monash University – Internal University Contribution, NIH - National Institutes of Health (United States of America), Cornell University, New York University, Francis Crick Institute, Scuola Internazionale Superiore di Studi Avanzati (International School for Advanced Studies), Duke University, Cold Spring Harbor Laboratory, RIKEN
25/06/14 → 31/12/21
Project: Research